Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
CStone Pharmaceuticals (2616 HK)
Watchlist
89
Analysis
Health Care
•
Hong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
23 Jan 2022 09:15
China Healthcare Weekly (Jan.21)-Growth Hormone VBP,Biotech Survival,Internationalization Conditions
We analyzed the impact of growth hormone/blood products VBP; the "reconsideration" of biotech IPO in primary market, survival problem of listed...
Xinyao (Criss) Wang
Follow
254 Views
Share
bullish
•
Thematic (Sector/Industry)
•
27 Dec 2021 09:13
China Healthcare Weekly (Dec.24)- Capital Arbitrage, Drug Commercial Results, Healthcare Big Picture
This insight analyzed the concerns on capital arbitrage in domestic innovative drugs, the unsatisfactory innovative drug commercial results,...
Xinyao (Criss) Wang
Follow
347 Views
Share
bearish
•
Jiangsu Hengrui Medicine
•
24 Nov 2021 09:09
Jiangsu Hengrui Medicine (600276.CH)-The Deal with Cstone,the Accounting Estimate Change and Outlook
The article analyzed Hengrui in terms of the logic and the potential impact of the deal with CStone and the accounting estimate change,the short...
Xinyao (Criss) Wang
Follow
226 Views
Share
bullish
•
Abbisko Cayman
•
23 Sep 2021 15:48
Abbisko IPO: A Promising but Longer Term Prognosis
While both core products are at an early stage of development, promising trials, management’s track record and blue-chip backers suggest that the...
Arun George
Follow
395 Views
Share
bullish
•
Thematic (Sector/Industry)
•
20 Sep 2021 09:01
China Healthcare Weekly (Sep17) - A New Round of Rebalancing, Artificial Joints VBP, Genetic Testing
The article mainly analyzed the logic of volume-based purchase (VBP) and healthcare sector rebalancing, the results of centralized procurement of...
Xinyao (Criss) Wang
Follow
242 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x